THR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. THR is in a strong uptrend, but it’s trading at/above near-term resistance with an overbought short-term RSI and a statistically weak 1-month forward pattern (-8.51% expected). With earnings on 2026-02-05 pre-market (Est. EPS 0.59) as the next major catalyst and price already extended, the risk/reward for an impatient entry is unfavorable today. I would hold (or wait for a pullback toward ~43 or lower) rather than buy at 45.25.
Trend is bullish but stretched. Moving averages are strongly bullish (SMA_5 > SMA_20 > SMA_200), and MACD histogram is positive and expanding (0.321), confirming upside momentum. However, RSI_6 is high at 76.283 (effectively overbought/extended), increasing the probability of a near-term pullback or consolidation. Key levels: Pivot 42.97 (first area a pullback could retest), Resistance R1 45.151 (price is essentially at/just above this level in post-market), next resistance R2 46.499; Support S1 40.789. Pattern-based forecast: +1.64% next day, +1.19% next week, but -8.51% next month—suggesting the current setup may be late-stage for chasing.
Intellectia Proprietary Trading Signals
Upcoming earnings catalyst: Q3 results (period ending Mar 31,
on 2026-02-05 pre-market with a webcasted call—potential upside if they beat/raise again.
Fundamentals trend is strong (see 2026/Q2 growth).
Technical trend remains upward (bullish MA stack + positive MACD).
Option open interest positioning is heavily call-skewed (bullish bias).
Price is extended near resistance (R1 ~45.151; next R2 ~46.
with RSI_6 ~76, increasing pullback risk.
Pattern-based forward signal shows meaningful 1-month downside bias (-8.51%).
Earnings event risk on 2026-02-05: even strong companies can sell off on guidance or expectations.
Analyst price target cited ($
is well below the current price (~45.25), implying limited upside per that (older) view.
Hedge funds and insiders show neutral activity—no strong “smart money” accumulation signal recently.
Latest reported quarter: 2026/Q2. Growth trends were strong: Revenue 131.723M (+14.89% YoY), Net Income 14.954M (+57.51% YoY), EPS 0.45 (+60.71% YoY), and Gross Margin 43.71% (+5.48% YoY). This combination (accelerating earnings vs revenue plus margin expansion) is a clear quality signal and supports the longer-term bullish thesis, even if the near-term entry looks stretched.
Recent analyst update provided: On 2025-11-07, Roth Capital (Chip Moore) reiterated a Buy and raised the price target to $38 from $33 after a Q2 beat and guidance raise, highlighting strategy/diversification and exposure to decarbonization/electrification themes. Pros (Wall St view): business momentum, diversification, and structural tailwinds. Cons: the cited price target ($38) is below the current trading level (~45.25), suggesting that either the target is stale versus current pricing or that sell-side upside is not compelling at this level based on that note. No other recent rating/target changes were provided.
